June 17 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- U.S. FDA AWARDS ORPHAN DRUG DESIGNATION TO PAXALISIB FOR AT/RT
News: KZA Kazia Therapeutics Says U.S. FDA Awards Orphan Drug Designation To Paxalisib
Add to My Watchlist
What is My Watchlist?